Cargando…
Novel FHL1 mutation variant identified in a patient with nonobstructive hypertrophic cardiomyopathy and myopathy – a case report
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a genetic disorder mostly caused by sarcomeric gene mutations, but almost 10% of cases are attributed to inherited metabolic and neuromuscular disorders. First described in 2008 in an American-Italian family with scapuloperoneal myopathy, FHL1 gene en...
Autores principales: | Giucă, Adrian, Mitu, Cristina, Popescu, Bogdan Ovidiu, Bastian, Alexandra Eugenia, Capşa, Răzvan, Mursă, Adriana, Rădoi, Viorica, Popescu, Bogdan Alexandru, Jurcuţ, Ruxandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525989/ https://www.ncbi.nlm.nih.gov/pubmed/32993534 http://dx.doi.org/10.1186/s12881-020-01131-w |
Ejemplares similares
-
Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire
por: Capota, Razvan, et al.
Publicado: (2020) -
Sclerodermic Cardiomyopathy—A State-of-the-Art Review
por: Giucă, Adrian, et al.
Publicado: (2022) -
Novel FHL1 Mutation Associated With Hypertrophic Cardiomyopathy, Sudden Cardiac Death, and Myopathy
por: Binder, M. Scott, et al.
Publicado: (2020) -
Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2022) -
Rare presentation and wide intrafamilial variability of Fabry disease: A case report and review of the literature
por: Militaru, Sebastian, et al.
Publicado: (2019)